KBI Biopharma Awarded as Global Leader in Biologics Manufacturing
Durham, North Carolina (April 3, 2025) – KBI Biopharma, a JSR Life Sciences Company and leading global contract development and manufacturing...
KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate
KBI Biopharma Selected as CDMO of Choice to Fast-Track Development of Pre-Clinical Antibody for Blood Cancers Using SUREmAbTM Technology Durham,...
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
Extension reinforces KBI’s commitment to forge long-term partnerships to successfully address complex clinical development and commercialization...